Judging by how the Street is reacting one just get the impression that Tandem’s results were below expectations. That the Control IQ isn’t just killing it and driving Tandem to new heights. Now to be honest we could care less what the Street thinks or how they react as they have been wrong so many times it’s ridiculous to even pay attention to what they do. Listen the results were just fine and pretty much what we expected.
We also suspect the company is taking a page from the Dexcom playbook preferring to lowball guidance only then . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.